Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Louise Bønnelykke Behrndtz"'
Autor:
Jens Ejrnæs Tønder, Marie Louise Bønnelykke-Behrndtz, Tinne Laurberg, Eeva-Liisa Røssell, Martin Sollie
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Cancer has become the leading diabetes-related cause of death in high-income countries, and more knowledge is needed to clarify the impact of diabetes on site-specific cancers. The purpose of this study is to assess the associatio
Externí odkaz:
https://doaj.org/article/22b4698b8252480398d0aecbcfadacc7
Autor:
Louise Bønnelykke-Behrndtz, Marie, Clasen, Mathias, Benckendorff, Josephine N.E., Kristjansen, Karoline Assifuah, Høyer, Linea, Mensel, Camilla, Nanthan, Kumanan, Andersen, Marc M.
Publikováno v:
In Brain Behavior and Immunity January 2025 123:1042-1051
Autor:
Henrik Schmidt, Lisbet Rosenkrantz Hölmich, Karoline Assifuah Kristjansen, Andreas Engel Krag, Marie Louise Bønnelykke-Behrndtz
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction Inflammation is a hallmark of cancer and is involved in tumour growth and dissemination. However, the hallmarks of cancer are also the hallmarks of wound healing, and modulating the wound inflammatory response and immune contexture in re
Externí odkaz:
https://doaj.org/article/bb3c66b98a72459e9e8c62b04dca77b2
Autor:
Marie Louise Bønnelykke-Behrndtz, Kasper Bruun Kristensen, Lisbet Rosenkrantz Hölmich, Anton Pottegård
Publikováno v:
Bønnelykke-Behrndtz, M L, Kristensen, K B, Hölmich, L R & Pottegård, A 2023, ' Tranexamic acid use is not associated with the risk of melanoma in Danish women : A nested case-control study using Danish health registries ', Cancer Epidemiology, vol. 84, 102356 . https://doi.org/10.1016/j.canep.2023.102356
Background: Repurposing already approved drugs in a cancer setting has gained increasing interest in recent years. Tranexamic acid is an anti-fibrinolytic drug that has recently been suggested as an anti-cancer drug due to its anti-inflammatory and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd4093d01b2828056a357dbcdeb644c
https://pure.au.dk/portal/da/publications/tranexamic-acid-use-is-not-associated-with-the-risk-of-melanoma-in-danish-women(bf7574c8-eb9d-4d0c-9e27-0639a9dadd50).html
https://pure.au.dk/portal/da/publications/tranexamic-acid-use-is-not-associated-with-the-risk-of-melanoma-in-danish-women(bf7574c8-eb9d-4d0c-9e27-0639a9dadd50).html
Autor:
Martin Heje, Rune Thomsen, Simon Naseri, Jeanette Bæhr Georgsen, Morten Ladekarl, Marie Louise Bønnelykke-Behrndtz, Torben Steiniche, Tine Engberg Damsgaard
Publikováno v:
Naseri, S, Steiniche, T, Georgsen, J B, Thomsen, R, Ladekarl, M, Heje, M, Damsgaard, T E & Bønnelykke-Behrndtz, M L 2020, ' Tumor ulceration, reduced infiltration of CD8-lymphocytes, high neutrophil-to-CD8-lymphocyte ratio and absence of MC virus are negative prognostic markers for patients with merkel cell carcinoma ', Cancers, vol. 12, no. 4, 888 . https://doi.org/10.3390/cancers12040888
Cancers
Volume 12
Issue 4
Naseri, S, Steiniche, T, Georgsen, J B, Thomsen, R, Ladekarl, M, Heje, M, Damsgaard, T E & Bønnelykke-Behrndtz, M L 2020, ' Tumor Ulceration, Reduced Infiltration of CD8-Lymphocytes, High Neutrophil-to-CD8-Lymphocyte Ratio and Absence of MC Virus are Negative Prognostic Markers for Patients with Merkel Cell Carcinoma ', Cancers, vol. 12, no. 4, 888, pp. 1-11 . https://doi.org/10.3390/cancers12040888
Cancers, Vol 12, Iss 888, p 888 (2020)
Cancers
Volume 12
Issue 4
Naseri, S, Steiniche, T, Georgsen, J B, Thomsen, R, Ladekarl, M, Heje, M, Damsgaard, T E & Bønnelykke-Behrndtz, M L 2020, ' Tumor Ulceration, Reduced Infiltration of CD8-Lymphocytes, High Neutrophil-to-CD8-Lymphocyte Ratio and Absence of MC Virus are Negative Prognostic Markers for Patients with Merkel Cell Carcinoma ', Cancers, vol. 12, no. 4, 888, pp. 1-11 . https://doi.org/10.3390/cancers12040888
Cancers, Vol 12, Iss 888, p 888 (2020)
(1) Background: Merkel cell carcinoma (MCC) is caused by the Merkel cell polyomavirus and UV radiation. Understanding of the underlying biology is limited, but identification of prognostic markers may lead to better prognostic stratification for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2368c61c70afa2b92905bf0c52dbbc13
https://pure.au.dk/portal/da/publications/tumor-ulceration-reduced-infiltration-of-cd8lymphocytes-high-neutrophiltocd8lymphocyte-ratio-and-absence-of-mc-virus-are-negative-prognostic-markers-for-patients-with-merkel-cell-carcinoma(367f0218-1e5a-4a34-afc4-d526f71d2432).html
https://pure.au.dk/portal/da/publications/tumor-ulceration-reduced-infiltration-of-cd8lymphocytes-high-neutrophiltocd8lymphocyte-ratio-and-absence-of-mc-virus-are-negative-prognostic-markers-for-patients-with-merkel-cell-carcinoma(367f0218-1e5a-4a34-afc4-d526f71d2432).html
Autor:
Jeanette Bæhr Georgsen, Torben Steiniche, Nina Dabrosin, Karen Sloth Juul, Henrik Schmidt, Simon Andrup, Louise Bønnelykke Behrndtz, Trine Heide Øllegaard
Publikováno v:
Dabrosin, N, Sloth Juul, K, Bæhr Georgsen, J, Andrup, S, Schmidt, H, Steiniche, T, Heide Øllegaard, T & Bønnelykke Behrndtz, L 2019, ' Innate immune cell infiltration in melanoma metastases affects survival and is associated with BRAFV600E mutation status ', Melanoma Research, vol. 29, no. 1, pp. 30-37 . https://doi.org/10.1097/CMR.0000000000000515
Little is known about the infiltrative pattern of innate immune cells in primary melanoma compared with their paired metastases and in BRAF-mutated tumors. Therefore, our aim was to characterize the inflammatory microenvironment in primary ulcerated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987b24d6813e9a79a9a3d83e1c3576c7
https://pure.au.dk/portal/da/publications/innate-immune-cell-infiltration-in-melanoma-metastases-affects-survival-and-is-associated-with-brafv600e-mutation-status(ff34db77-fabe-4ea1-b197-18309530c40e).html
https://pure.au.dk/portal/da/publications/innate-immune-cell-infiltration-in-melanoma-metastases-affects-survival-and-is-associated-with-brafv600e-mutation-status(ff34db77-fabe-4ea1-b197-18309530c40e).html
Autor:
Simon Naseri, Lisbet Rosenkrantz Hölmich, Niels Junker, Seppo W. Langer, Torben Steiniche, Morten Ladekarl, Alessandro Venzo, Marie Louise Bønnelykke-Behrndtz, Mathilde S. Larsen, Elizaveta Mitkina Tabaksblat, Annette H. Chakera, Siri Klausen
Publikováno v:
Naseri, S, Steiniche, T, Ladekarl, M, Bønnelykke-Behrndtz, M L, Hölmich, L R, Langer, S W, Venzo, A, Tabaksblat, E, Klausen, S, Skaarup Larsen, M, Junker, N & Chakera, A H 2020, ' Management Recommendations for Merkel Cell Carcinoma-A Danish Perspective ', Cancers, vol. 12, no. 3, 554 . https://doi.org/10.3390/cancers12030554
Cancers, Vol 12, Iss 3, p 554 (2020)
Naseri, S, Steiniche, T, Ladekarl, M, Bønnelykke-Behrndtz, M L, Hölmich, L R, Langer, S W, Venzo, A, Tabaksblat, E, Klausen, S, Larsen, M S, Junker, N & Chakera, A H 2020, ' Management recommendations for merkel cell carcinoma : a Danish perspective ', Cancers, vol. 12, no. 3, 554 . https://doi.org/10.3390/cancers12030554
Cancers
Naseri, S, Steiniche, T, Ladekarl, M, Bønnelykke-Behrndtz, M L, Hölmich, L R, Langer, S W, Venzo, A, Tabaksblat, E, Klausen, S, Larsen, M S, Junker, N & Chakera, A H 2020, ' Management Recommendations for Merkel Cell Carcinoma : A Danish Perspective ', Cancers, vol. 12, no. 3, 554 . https://doi.org/10.3390/cancers12030554
Cancers, Vol 12, Iss 3, p 554 (2020)
Naseri, S, Steiniche, T, Ladekarl, M, Bønnelykke-Behrndtz, M L, Hölmich, L R, Langer, S W, Venzo, A, Tabaksblat, E, Klausen, S, Larsen, M S, Junker, N & Chakera, A H 2020, ' Management recommendations for merkel cell carcinoma : a Danish perspective ', Cancers, vol. 12, no. 3, 554 . https://doi.org/10.3390/cancers12030554
Cancers
Naseri, S, Steiniche, T, Ladekarl, M, Bønnelykke-Behrndtz, M L, Hölmich, L R, Langer, S W, Venzo, A, Tabaksblat, E, Klausen, S, Larsen, M S, Junker, N & Chakera, A H 2020, ' Management Recommendations for Merkel Cell Carcinoma : A Danish Perspective ', Cancers, vol. 12, no. 3, 554 . https://doi.org/10.3390/cancers12030554
Merkel cell carcinoma (MCC) is a rare malignant neuroendocrine carcinoma of the skin with a poor prognosis and an apparent increase in incidence. Due to its rarity, evidence-based guidelines are limited, and there is a lack of awareness among clinici
Autor:
Torben Steiniche, Karen Sloth, Marie Louise Bønnelykke-Behrndtz, Johanne Lade-Keller, Nina Dabrosin, Line B Nielsen
Publikováno v:
Nielsen, L B, Dabrosin, N, Sloth, K, Bønnelykke-Behrndtz, M L, Steiniche, T & Lade-Keller, J 2018, ' Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases ', Histopathology, vol. 72, no. 5, pp. 814-825 . https://doi.org/10.1111/his.13431
AIMS: The present study analysed the usability of an immunohistochemical (IHC) analysis compared to a frequently used mutation detection analysis and examined the extent of intra- and inter-tumour heterogeneity of BRAF V600E in primary tumours and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a37a6b0e109e7970eaef852b1aa8354
https://pure.au.dk/portal/da/publications/concordance-in-braf-v600estatus-over-time-in-malignant-melanoma-and-corresponding-metastases(35fd0517-256e-424d-bd3e-0de53327ef3d).html
https://pure.au.dk/portal/da/publications/concordance-in-braf-v600estatus-over-time-in-malignant-melanoma-and-corresponding-metastases(35fd0517-256e-424d-bd3e-0de53327ef3d).html
Publikováno v:
Cutaneous Melanoma: Etiology and Therapy ISBN: 9780994438140
Ulceration is an important prognostic factor for patients with melanoma and also a predictive marker for the response of adjuvant immune-stimulating therapy. A consensual definition and accurate assessment of ulceration is therefore crucial for pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b3f28b5fe8be001e2c7b878da3c8cf9
https://doi.org/10.15586/codon.cutaneousmelanoma.2017.ch5
https://doi.org/10.15586/codon.cutaneousmelanoma.2017.ch5
Autor:
Lars Bastholt, Tine Engberg Damsgaard, Henrik Schmidt, Allan V Danielsen, Peter Nørgaard, Torben Steiniche, Ib J. Christensen, Marie Louise Bønnelykke-Behrndtz, Holger Jon Møller
Publikováno v:
Bønnelykke-Behrndtz, M L, Steiniche, T, Nørgaard, P, Danielsen, A V, Damsgaard, T E, Christensen, I J, Bastholt, L, Møller, H J & Schmidt, H 2017, ' Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration ', American Journal of Dermatopathology, vol. 39, no. 9, pp. 672–678 . https://doi.org/10.1097/DAD.0000000000000750
Bønnelykke-Behrndtz, M L, Steiniche, T, Nørgaard, P, Danielsen, A V, Damsgaard, T E, Christensen, I J, Bastholt, L, Møller, H J & Schmidt, H 2017, ' Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration ', American Journal of Dermatopathology, vol. 39, no. 9, pp. 672-678 . https://doi.org/10.1097/DAD.0000000000000750
Bønnelykke-Behrndtz, M L, Steiniche, T, Nørgaard, P, Danielsen, A V, Damsgaard, T E, Christensen, I J, Bastholt, L, Møller, H J & Schmidt, H 2017, ' Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration ', American Journal of Dermatopathology, vol. 39, no. 9, pp. 672-678 . https://doi.org/10.1097/DAD.0000000000000750
It has been suggested that embryogenic properties of migratory cells are reactivated during wound healing and metastasis in adults. This might explain the association between wound-induced inflammation and poor survival in patients with ulcerated mel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5df6314b00fd822f28c92ffaa9eb59
https://portal.findresearcher.sdu.dk/da/publications/3b3d79cc-4ec2-495e-b557-28a89eb798c2
https://portal.findresearcher.sdu.dk/da/publications/3b3d79cc-4ec2-495e-b557-28a89eb798c2